Christos K Kontos Selected Research

Christos K Kontos Research Topics

Disease

49	Neoplasms (Cancer) 06/2024 - 12/2008
16	Adenocarcinoma 10/2021 - 10/2012
13	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2023 - 01/2011
10	Breast Neoplasms (Breast Cancer) 03/2024 - 10/2010
9	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2010
8	Colorectal Neoplasms (Colorectal Cancer) 05/2022 - 05/2014
7	Prostatic Neoplasms (Prostate Cancer) 12/2023 - 10/2012
7	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2020 - 03/2013
5	Multiple Myeloma 01/2024 - 02/2021
5	Carcinogenesis 10/2021 - 01/2016
4	Squamous Cell Carcinoma of Head and Neck 08/2016 - 10/2012
3	Nasopharyngeal Carcinoma 02/2013 - 10/2010
2	Hepatocellular Carcinoma (Hepatoma) 06/2024 - 11/2023
2	Leukemia 10/2023 - 04/2016
2	Skin Neoplasms (Skin Cancer) 12/2021 - 01/2016
2	Bone Diseases (Bone Disease) 07/2021 - 02/2021
2	Lymphoma (Lymphomas) 03/2021 - 11/2020
2	Hematologic Neoplasms (Hematological Malignancy) 02/2021 - 02/2021
2	Lung Neoplasms (Lung Cancer) 02/2021 - 10/2020
2	Carcinoma (Carcinomatosis) 11/2020 - 03/2011
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 11/2013
2	Colonic Neoplasms (Colon Cancer) 05/2019 - 12/2008
1	Plasma Cell Neoplasms 01/2024
1	Hyperplasia 12/2023
1	Pathologic Processes 12/2023
1	Triple Negative Breast Neoplasms 09/2023
1	Skin Diseases (Skin Disease) 12/2021
1	Disease Progression 12/2021
1	Osteoporosis 07/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 03/2021
1	Sarcoma (Soft Tissue Sarcoma) 11/2020
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2019
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 11/2018
1	Inflammation (Inflammations) 01/2017
1	Melanoma (Melanoma, Malignant) 01/2016
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2016

Drug/Important Bio-Agent (IBA)

43	Biomarkers (Surrogate Marker)IBA 01/2024 - 12/2008
23	Messenger RNA (mRNA)IBA 08/2022 - 10/2010
21	RNA (Ribonucleic Acid)IBA 01/2024 - 02/2013
18	MicroRNAs (MicroRNA)IBA 12/2023 - 03/2013
10	Circular RNAIBA 03/2024 - 08/2020
9	Proteins (Proteins, Gene)FDA Link 11/2018 - 10/2010
6	Transfer RNA (tRNA)IBA 12/2021 - 10/2019
6	Azacitidine (5 Azacytidine)FDA Link 01/2020 - 01/2016
6	Tumor Biomarkers (Tumor Markers)IBA 09/2018 - 12/2008
5	Indicators and Reagents (Reagents)IBA 01/2024 - 03/2011
5	Kallikreins (Kallikrein)IBA 01/2019 - 03/2013
5	Peptide Hydrolases (Proteases)FDA Link 01/2019 - 03/2013
4	Carboxy-LyasesIBA 02/2021 - 10/2012
4	Levodopa (L Dopa)FDA LinkGeneric 02/2021 - 10/2012
3	Antineoplastic Agents (Antineoplastics)IBA 12/2023 - 03/2014
3	Prostate-Specific Antigen (Semenogelase)IBA 07/2020 - 11/2012
3	Tissue Kallikreins (Tissue Kallikrein)IBA 01/2019 - 05/2014
3	Transcription Factors (Transcription Factor)IBA 01/2017 - 08/2013
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 08/2022 - 01/2020
2	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 01/2022 - 05/2019
2	Histones (Histone)IBA 01/2022 - 08/2013
1	Miat long non-coding RNAIBA 06/2024
1	Long Noncoding RNAIBA 06/2024
1	28S Ribosomal RNAIBA 12/2023
1	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2023
1	Proteasome InhibitorsIBA 12/2023
1	Immune Checkpoint ProteinsIBA 11/2023
1	Olive OilIBA 09/2023
1	oleuropeinIBA 09/2023
1	oleocanthalIBA 09/2023
1	CaspasesIBA 08/2022
1	oligo (dT)IBA 05/2022
1	Pro Transfer RNAIBA 05/2022
1	RetinoidsIBA 12/2021
1	Circulating MicroRNAIBA 07/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2021
1	CateninsIBA 06/2021
1	TrypsinIBA 07/2020
1	Molecular Chaperones (Chaperone, Molecular)IBA 01/2020
1	ClusterinIBA 01/2020
1	RNA IsoformsIBA 11/2019
1	SteroidsIBA 05/2019
1	Hormones (Hormone)IBA 05/2019
1	Fluorouracil (Carac)FDA LinkGeneric 01/2018
1	Vinblastine (Vinblastine Sulfate)FDA Link 01/2018
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2018
1	Vinca AlkaloidsIBA 01/2018
1	Antimitotic AgentsIBA 01/2018
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018
1	Leucovorin (Folinic Acid)FDA Link 01/2018
1	Vincristine (Oncovin)FDA LinkGeneric 01/2018
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2018
1	alpha Subunit Hypoxia-Inducible Factor 1IBA 01/2017
1	Serine EndopeptidasesIBA 02/2016
1	B7-H1 AntigenIBA 02/2016
1	Rituximab (Mabthera)FDA Link 01/2016

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 11/2018 - 11/2012
4	Therapeutics 11/2020 - 08/2013
4	Radiotherapy 01/2018 - 01/2014
2	Precision Medicine 06/2024 - 11/2012
1	Immunotherapy 11/2023
1	PVDA protocol 11/2018
1	Aftercare (After-Treatment) 03/2014